Log In
Print
BCIQ
Print
Print this Print this
 

LY500307

  Manage Alerts
Collapse Summary General Information
Company Eli Lilly and Co.
Description 
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase II
Standard IndicationBenign prostatic hyperplasia (BPH)
Indication DetailsTreat benign prostatic hyperplasia (BPH)
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today